Emerging addictive substances include synthetic drugs like designer opioids and cannabinoids with unpredictable effects and high abuse potential. These substances often bypass regulations, posing significant health risks and challenges in detection. Their rapid proliferation demands ongoing research and monitoring. Collaborative efforts are crucial to mitigate their impact and enhance prevention strategies.
Tracks
1. Synthetic Cannabinoid Risks
2. Designer Opioids and Health Impact
3. Emerging Stimulants Trends
4. Novel Psychoactive Substances (NPS)
5. Detection of Emerging Drugs
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
